Bridgewater Associates’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.81M	Buy	23,161 +19,088	+469%	+$4.75M	0.03%	389
2025 Q4	$1.12M	Buy	+4,073	New	+$1.11M	﹤0.01%	867
2024 Q2	–	Sell	-1,292	Closed	-$511K	–	945
2024 Q1	$511K	Sell	1,292 -3,101	-71%	-$1.15M	﹤0.01%	621
2023 Q4	$1.55M	Sell	4,393 -262	-6%	-$92.7K	0.01%	568
2023 Q3	$1.75M	Sell	4,655 -280	-6%	-$108K	0.01%	517
2023 Q2	$1.89M	Sell	4,935 -30	-0.6%	-$10.7K	0.01%	469
2023 Q1	$1.72M	Sell	4,965 -7,254	-59%	-$2.12M	0.01%	485
2022 Q4	$2.88M	Sell	12,219 -29,858	-71%	-$7.08M	0.02%	466
2022 Q3	$10.4M	Buy	42,077 +18,921	+82%	+$5.76M	0.05%	248
2022 Q2	$7M	Buy	23,156 +12,266	+113%	+$3.99M	0.03%	411
2022 Q1	$4.47M	Buy	10,890 +2,525	+30%	+$988K	0.02%	496
2021 Q4	$3.92M	Sell	8,365 -75,708	-90%	-$32.6M	0.02%	349
2021 Q3	$35.7M	Sell	84,073 -3,495	-4%	-$1.47M	0.2%	96
2021 Q2	$31.4M	Buy	87,568 +39,073	+81%	+$12.9M	0.2%	90
2021 Q1	$13.7M	Buy	48,495 +6,132	+14%	+$1.75M	0.12%	132
2020 Q4	$12M	Buy	42,363 +24,718	+140%	+$6.94M	0.1%	108
2020 Q3	$4.85M	Buy	+17,645	New	+$4.67M	0.06%	142